Obiettivo This Marie Curie Excellence Grant proposal by team Leader N. Callewert focuses on the application of a technology core for the isolation, analysis and bioengineering of mannosylated glycoconjugates. This technology core is now sufficiently advanced to explore its utility in tackling a number of long-standing biomedical and biotechnological challenges: vaccine design, genomic analysis of pathogen glycoconjugate biosynthesis pathways, and production of sufficient quantities of homogenously glycosylated proteins for structural analysis. Campo scientifico medical and health sciencesbasic medicineimmunologyimmunisationnatural sciencesbiological sciencesmicrobiologyvirologynatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccinesnatural sciencesbiological sciencesbiochemistrybiomoleculescarbohydrates Programma(i) FP6-MOBILITY - Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006 Argomento(i) MOBILITY-3.1 - Marie Curie Excellence Grants (EXT) Invito a presentare proposte FP6-2002-MOBILITY-8 Vedi altri progetti per questo bando Meccanismo di finanziamento EXT - Marie Curie actions-Grants for Excellent Teams Coordinatore FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW Contributo UE Nessun dato Indirizzo Rijvisschestraat 120 ZWIJNAARDE Belgio Mostra sulla mappa Collegamenti Sito web Opens in new window Costo totale Nessun dato
